Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelorAnne Bertling, Beate E. Kehrel, Lisa Schüngel et al.|Journal of Thrombosis and Haemostasis|2018Cited by 32
Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytesClaudia Mittendorff, Anke C. Fender|Naunyn-Schmiedeberg s Archives of Pharmacology|2024Cited by 5
The thrombin receptor PAR4 supports visceral adipose tissue inflammationS Kleeschulte, Anke C. Fender|Naunyn-Schmiedeberg s Archives of Pharmacology|2024Cited by 4